Luong Trach Huynh Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 812 5th St, Marysville, CA 95901 Phone: 530-743-4629 Fax: 530-743-8574 |
Jeffrey Fernandez Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1131 N Beale Rd, Marysville, CA 95901 Phone: 530-634-9760 |
Shivani Sharma Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 906 E St, Marysville, CA 95901 Phone: 530-742-5103 |
Kimberly Muhamach, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 906 E St, Marysville, CA 95901 Phone: 530-742-5103 |
Jasvinder Sandhu Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 906 E St, Marysville, CA 95901 Phone: 530-742-5103 |
Jindjeet Hansi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 812 5th St, Marysville, CA 95901 Phone: 530-743-4629 |
Parjinder Toor Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 906 E St, Marysville, CA 95901 Phone: 530-742-5103 |
Dr. Amarprit Singh Nijjar, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 602 10th St, Marysville, CA 95901 Phone: 530-743-2594 Fax: 530-743-0793 |
Mrs. Maria Alpena Briones Leonidas Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 602 10th St, Marysville, CA 95901 Phone: 530-743-2594 |
Christine S Zenzen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 602 10th St, Marysville, CA 95901 Phone: 530-743-2594 |
News Archive
California has succeeded in drastically reducing anonymous and undocumented gun sales and sales of military-style weapons by introducing tighter controls to gun shows reveals a study in the June issue of Injury Prevention.
New research, published in the Journal of American Society of Nephrology by The George Institute for International Health in Sydney, has found that lowering blood pressure protects stroke victims with Chronic Kidney Disease from further strokes or heart attacks.
Vitamin C administration shortened the length of stay in the intensive care unit on average by 8% in 12 trials with 1766 patients according to a meta-analysis published in Nutrients.
The U.S. Food and Drug Administration today issued warning letters to five distributors for various violations of the Federal Food, Drug, and Cosmetic Act (FDCA) including unsubstantiated claims and poor manufacturing practices.
New landmark data (the STAR Study), revealed today from the European Association of Urology in Istanbul, Turkey, show that patients suffering from Overactive Bladder (OAB) syndrome will see considerably better improvements in their symptoms when being treated with the new antimuscarinic drug solifenacin, than on tolterodine ER - an antimuscarinic drug that is widely used.
› Verified 9 days ago